Denosumab monoclonal antibody drug. Targets RANKL, indications for use include osteoporosis and bone metastases. Generic name and stylized antibody.

---

Size: 9000px × 3429px
Photo credit: © molekuul.be / Alamy / Afripics
License: Royalty Free
Model Released: No

Keywords: activator, antibody, biological, biosimilar, biotech, biotechnology, bone, denosumab, disease, drug, factor, fracture, immunoglobulin, immunology, infusion, inhibitor, injection, inn, jaw, kappa, loss, mab, metastasis, monoclonal, nomenclature, nuclear, osteoclast, osteonecrosis, osteoporosis, peptide, protein, rankl, receptor